NRXP
Q3 2026 EPS Estimate
$-0.09
Aug 17, 2026 · Reports before open
Revenue Estimate
$2M
FY2027E EPS$0.35
FY2028E EPS$2.49

Analyst Sentiment

Wall St. Consensus
Buy
5 analysts·Limited coverage
75
Score
5 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
5100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.00
-48.3%
Consensus
$2.00
-48.3%
Bull
$2.00
-48.3%
12-Month Target Range5 analysts
$2.00$2.00$2.00
Current $3.87Consensus
Current Price
$3.87
Above Consensus
$1.87

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+1091.94%
EPS
FY2028
Rev+201.21%
EPS+606.32%
FY2029
Rev+49.38%
EPS+81.12%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$14M$166M$499M$745M$935M
Low$13M$68M$156M$233M$292M
High$15M$263M$1.00B$1.50B$1.88B
EBITDA Avg$8M$99M$299M$447M$561M
Low$8M$41M$94M$140M$175M
High$9M$158M$601M$898M$1.13B
EBIT Avg$8M$99M$299M$447M$561M
Low$8M$41M$94M$140M$175M
High$9M$158M$601M$898M$1.13B
Net Income Avg$-8M$7M$64M$97M$123M
Low$-10M$6M$6M$10M$13M
High$-6M$9M$123M$223M$285M
EPS Avg$-0.37$0.35$2.49$4.51$5.76
Low$-0.45$0.30$0.26$0.48$0.61
High$-0.29$0.40$5.76$10.43$13.32
Analysts (Rev / EPS)2 / 23 / 21 / 11 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$3M$8M$28M$42M$59M$75M$274M$286M
Low$2M$5M$17M$26M$35M$45M$166M$172M
High$4M$12M$41M$62M$86M$109M$401M$418M
EBITDA Avg$2M$5M$17M$25M$35M$45M$165M$172M
Low$912,428$3M$10M$15M$21M$27M$99M$103M
High$2M$7M$25M$37M$51M$66M$241M$251M
EBIT Avg$2M$5M$17M$25M$35M$45M$165M$172M
Low$912,428$3M$10M$15M$21M$27M$99M$103M
High$2M$7M$25M$37M$51M$66M$241M$251M
Net Income Avg$-3M$-3M$-54,144$1M$3M$7M$170M$177M
Low$-4M$-5M$-86,614$683,343$2M$3M$82M$86M
High$-3M$-1M$-26,222$2M$5M$10M$272M$283M
EPS Avg$-0.11$-0.09$-0.00$0.04$0.10$0.20$5.27$5.48
Low$-0.12$-0.14$-0.00$0.02$0.05$0.10$2.55$2.65
High$-0.09$-0.04$-0.00$0.07$0.16$0.32$8.42$8.77
Analysts (Rev / EPS)2 / 11 / 11 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Jun 30, 2022H.C. Wainwright
NRx Pharmaceuticals (NRXP) Stock: Why It Increased Over 6% Today
Target:$2.00
+249.0%from $0.57
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.